7 Patents
- 0 cites
- US124484552025Combination Therapies with Bispecific Anti-egfr/c-met Antibodies and Third Generation EGFR Tyrosine Kinase Inhibitors
Janssen Biotech, Inc.
0 cites - 0 cites
- 0 cites
- 0 cites
- US122151612025Combination Therapies and Patient Stratification with Bispecific Anti-egfr/c-met Antibodies
Janssen Biotech, Inc.
0 cites - US118790132024Combination Therapies with Bispecific Anti-egfr/c-met Antibodies and Third Generation EGFR Tyrosine Kinase Inhibitors
JANSSEN BIOTECH, Inc.
0 cites